ACF Investors, established in 2011 and based in Sheffield, United Kingdom, operates as a venture capital entity that collaborates with experienced angel investors to support early-stage businesses. The firm focuses on co-investing alongside syndicates of angel investors, leveraging their sector-specific expertise to identify and fund high-potential companies. ACF Investors has built a strong portfolio, having invested over £40 million in partnership with more than £200 million from angel investors and other sources, resulting in a diverse collection of over 80 companies. The organization is dedicated to fostering the growth of small and medium-sized enterprises throughout the UK, often providing support through multiple funding rounds as these companies scale.
Hammer Missions is a comprehensive software platform that assists organizations in making informed decisions by utilizing drone data and artificial intelligence. The platform enables drone professionals and enterprise UAS programs to gather high-quality data on various structures, including roofs, facades, and towers. This data can be processed and analyzed into detailed maps, 3D models, and digital twins, along with asset inspection reports generated by its tools, Hamlet and Spector AI, which identify faults and anomalies. By serving a diverse clientele of drone service providers, engineering firms, and contractors, Hammer Missions is establishing itself as a leading solution for building inspections and critical infrastructure management, allowing organizations to act proactively based on the insights derived from the data collected.
FLIT
Venture Round in 2025
FLIT is a company that designs and manufactures lightweight folding electric bikes (e-bikes) specifically for urban commuters. Based in Cambridge, FLIT focuses on innovation and quality, offering compact and efficient solutions for city travel. The company's flagship product, the FLIT-16, represents a new generation of folding e-bikes that blend portability with performance. The FLIT M2 further enhances this concept with Rider-Centric Folding Bike Geometry, prioritizing user comfort and convenience. FLIT aims to transform urban commuting by providing a sustainable, flexible, and enjoyable alternative to traditional modes of transportation.
OneID
Venture Round in 2025
Developer of digital identity assurance technology designed to provide a frictionless online onboarding process for businesses. The company's digital identity assurance technology empowers individuals to leverage their identity, decide who has access to it and how they share it, along provides fraud detection, enabling users to manage their online identities and have a safe sign-up for new services online, without their data being accessed by unauthorized third parties.
Unum Aircraft Seating
Venture Round in 2025
Unum Aircraft Seating is a manufacturing company that provides aircraft seating design, manufacturing, and supply to the airline industry.
Silveray
Seed Round in 2024
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Hexigone Inhibitors
Venture Round in 2024
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primary resources.
Veremark
Series B in 2024
Veremark Ltd is a London-based company that specializes in online reference and background checking software solutions. Founded in 2018, it offers a comprehensive platform that enables businesses to verify candidates' credentials, including employment history, academic qualifications, and various background checks such as criminal, credit, and global sanctions checks. The platform also includes features like psychometric assessments and adverse media checks, ensuring compliance with regulations such as GDPR and PDPA. With additional offices in the Philippines and Singapore, Veremark aims to facilitate the hiring of qualified and trustworthy employees through its automated screening processes.
Neurovalens
Funding Round in 2024
Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.
Arrow Risk Management
Seed Round in 2024
Arrow Risk Management hopes to use the cash to expand its operations further and develop its underwriting platform.
Sonichem
Seed Round in 2024
Sonichem, formerly known as Bio-Sep, specializes in a biorefinery technology that utilizes ultrasonic reactors to transform by-products from forestry and sawmill operations into valuable bio-based chemicals, including sugars, cellulose, and pure lignin. This innovative process addresses the inefficiencies in wood utilization, as only 55% of harvested timber is typically converted into usable products. By converting each dollar's worth of sawdust into eight dollars of biochemicals, Sonichem's technology demonstrates significant economic potential. The process has been validated at both laboratory and pilot plant scales, showcasing a scalable reactor design for commercialization. Additionally, Sonichem holds patents in ten markets and was recognized as the 2021 winner of the Royal Society of Chemistry’s prize for Best Enabling Technology.
NumberEight
Seed Round in 2024
NumberEight develops on-device mobile AI software to enable content providers to deliver hyper-personalized experiences in real-time using mobile sensors.
Spotta
Series A in 2023
Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.
Reboxed
Seed Round in 2023
reboxed isn’t your average recommerce company. We are a combination of technology, branding, and environmental impact - an on-demand platform for businesses and people to sell, swap and shop for used tech because we believe great tech shouldn't cost the Earth. Our obsession with having the latest smartphone the second it drops is creating mountains of e-waste. Why? One, it's too much hassle to sell. Two, refurbished phones have a bad rep. Until now. We refurbish and rebox used devices into premium phones - making it easier, faster, and more trustworthy. So fewer perfectly good phones go to waste. And one by one, we can save millions more from landfill. Our circular business model – rebox, rehome, repeat – isn’t just designed to give our customers better value, but make a positive impact on the environment and society. We don’t just reward people for reboxing. We reward the planet by planting 10 trees every time we buy or sell a device and paying to offset each phone’s lifetime CO2 emissions, which helps to fund a whole range of projects to cut CO2. Our goal is to try and make every phone we rehome not just carbon neutral, but carbon positive if we can. We've come to shake up a dated and boring category. To solve inefficiencies. To redefine recommerce. To challenge the status quo. To liberate people from their addiction to linear, and create a circular economy that rewards them for making greener choices and helping to replenish the planet. One device at a time. We’re on a mission to 100 million phones by 2030. And transform the way people buy, sell, and think about tech. We are reboxed. Recommerce, on-demand
BirdsEyeView
Seed Round in 2023
BirdsEyeView is a London-based InsurTech venture functioning as a Managing General Agent. The company addresses the growing challenges posed by climate change, particularly the increasing frequency and severity of natural disasters. By utilizing advanced aerial intelligence, BirdsEyeView simplifies the collection and analysis of geospatial data. It leverages meteorological information from satellites, ground stations, and IoT devices to develop innovative parametric insurance solutions for climate-related risks. Their proprietary rating engine enables precise pricing of insurance at the individual farm level, allowing agricultural insurers to make informed decisions more rapidly.
OneID
Seed Round in 2023
Developer of digital identity assurance technology designed to provide a frictionless online onboarding process for businesses. The company's digital identity assurance technology empowers individuals to leverage their identity, decide who has access to it and how they share it, along provides fraud detection, enabling users to manage their online identities and have a safe sign-up for new services online, without their data being accessed by unauthorized third parties.
Huq Industries
Series A in 2023
Huq Industries is an independent research company that specializes in places and population mobility. The company operates a market intelligence data platform designed to establish standards in research, analysis, and consumer behavior measurement. Its offerings include tailor-made research products that align with the workflows and technical environments of various organizations. By employing advanced technologies and innovative mobility research methods, Huq provides insights that measure offline behavior across diverse activities. The company's clientele encompasses over 70 local councils, leading management consultancies, retailers, commercial real estate firms, and asset managers, highlighting its extensive reach in both the public and private sectors.
Wayland Additive
Series B in 2023
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
BlackCurve
Seed Round in 2023
BlackCurve is a company that specializes in pricing optimization for e-commerce businesses. It offers a platform that assists retailers in maximizing their profit potential through effective pricing strategies. The platform utilizes advanced algorithms and machine learning to develop pricing rules and models that assess the potential impact of these rules. Additionally, it continuously analyzes performance data to help businesses identify the optimal price points for their products and services. By providing insights into competitor pricing and enhancing digital marketing performance, BlackCurve enables its clients to make informed pricing decisions that can improve their overall profitability.
Something & Nothing
Seed Round in 2022
Something & Nothing specializes in seltzer made from natural ingredients and low in calories.
Oxford Medical Simulation
Seed Round in 2022
Oxford Medical Simulation Ltd. specializes in providing virtual reality (VR) simulation-based training solutions for healthcare professionals, including doctors and nurses. Founded in 2017 and headquartered in London, with an additional office in Boston, the company offers immersive VR scenarios that allow users to manage patient care in a realistic environment. These simulations enable healthcare workers to perform investigations, initiate treatment, and collaborate with their team, all while receiving objective feedback on their performance. This feedback highlights strengths, team management skills, and areas for improvement. By offering a customizable and evidence-based approach, Oxford Medical Simulation aims to make high-quality medical training more accessible and cost-effective, addressing the challenges of traditional simulation methods that can be expensive and limited in scope.
Silveray
Seed Round in 2022
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Veremark
Series A in 2022
Veremark Ltd is a London-based company that specializes in online reference and background checking software solutions. Founded in 2018, it offers a comprehensive platform that enables businesses to verify candidates' credentials, including employment history, academic qualifications, and various background checks such as criminal, credit, and global sanctions checks. The platform also includes features like psychometric assessments and adverse media checks, ensuring compliance with regulations such as GDPR and PDPA. With additional offices in the Philippines and Singapore, Veremark aims to facilitate the hiring of qualified and trustworthy employees through its automated screening processes.
Konsileo
Series A in 2022
Konsileo Limited is a commercial insurance broker based in London, United Kingdom, founded in 2015. The company utilizes an innovative online platform that includes features such as Fact Find and Risk Hub, which facilitate efficient data capture and regulatory compliance. This technology allows brokers to streamline their operations, providing them with more time to focus on client relationships. Konsileo's approach promotes collaboration among brokers by fostering a community-oriented environment that prioritizes professional support and expertise sharing, rather than a traditional hierarchical structure. The platform also offers clients easy access to information regarding premiums, policy duration, and downloadable insurance documents, enhancing the overall risk management experience.
Sonichem
Seed Round in 2022
Sonichem, formerly known as Bio-Sep, specializes in a biorefinery technology that utilizes ultrasonic reactors to transform by-products from forestry and sawmill operations into valuable bio-based chemicals, including sugars, cellulose, and pure lignin. This innovative process addresses the inefficiencies in wood utilization, as only 55% of harvested timber is typically converted into usable products. By converting each dollar's worth of sawdust into eight dollars of biochemicals, Sonichem's technology demonstrates significant economic potential. The process has been validated at both laboratory and pilot plant scales, showcasing a scalable reactor design for commercialization. Additionally, Sonichem holds patents in ten markets and was recognized as the 2021 winner of the Royal Society of Chemistry’s prize for Best Enabling Technology.
Spirea
Venture Round in 2022
Spirea Ltd. is a healthcare technology company based in Harrogate, United Kingdom, that specializes in developing antibody drug conjugates (ADCs) for cancer treatment. Founded in 2015, Spirea has created a smart polymer platform designed for the controlled delivery of drug combinations, thereby maximizing the clinical efficacy of therapies. The company's innovative approach to ADCs allows for a greater amount of drug payload to be specifically targeted to tumor cells, resulting in enhanced therapeutic effects while significantly minimizing side effects. This development enables healthcare providers to offer well-tolerated treatment options for a variety of cancers, ultimately aiming to improve the quality of life for patients.
Smile Plastics
Venture Round in 2022
Smile Plastics manufactures hand-crafted panels from recycled plastics. Materials used by Smile Plastics range from mobile phones and confiscated CDs to wellington boots and yogurt pots. The panels are suitable for decorative architectural and design projects and have been used in a wide range of applications in high profile locations like the V&A, the Design Museum and Tate Gallery as well as in shop fit outs, and in furniture and fittings.
Oxford Drug Design
Convertible Note in 2022
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
Monterosa Productions
Venture Round in 2022
Monterosa Productions Ltd specializes in audience interaction technology, offering a cloud platform that enhances engagement for content creators and developers across various media. The company provides a suite of products that facilitate live games, voting, competitions, and sports experiences, specifically designed for television shows and events. Its key offerings include LViS for television, a scalable interaction platform with embeddable applications; LViS for brands, which integrates interactive content across multiple screens; and LViS for sports, enabling audience participation through tracking, voting, and gaming. Monterosa collaborates with prominent clients in the entertainment and sports sectors, such as the BBC, ITV, and the English Premier League, to create immersive experiences that boost audience interactivity and loyalty. With a foundation established in 2003 and offices in London, Liverpool, and Minsk, the company boasts a team of experts dedicated to delivering reliable and innovative interactive solutions.
BLOK London
Seed Round in 2022
BLOK is one of London’s leading boutique class based gyms, combining fitness with art, design, and fashion.
Wayland Additive
Series A in 2021
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
HUBX
Series A in 2021
Designed by seasoned capital markets professionals, HUBX empowers investment professionals to manage their workflows and relationships with insight, intelligence and control. HUBX provides an out of the box solution for advisors to manage deals from origination to distribution. Suitable for: • Brokers and Deal Introducers • Investment Syndicates • Wealth managers and Private Banks • Corporate Finance Advisors • Investment Banks • Stock Exchanges HUBX technology powers the London Stock Exchange Group’s ELITE private placement platform connecting high growth companies with LSEG’s global institutional investor network. Regulated by the FCA.
Veremark
Seed Round in 2021
Veremark Ltd is a London-based company that specializes in online reference and background checking software solutions. Founded in 2018, it offers a comprehensive platform that enables businesses to verify candidates' credentials, including employment history, academic qualifications, and various background checks such as criminal, credit, and global sanctions checks. The platform also includes features like psychometric assessments and adverse media checks, ensuring compliance with regulations such as GDPR and PDPA. With additional offices in the Philippines and Singapore, Veremark aims to facilitate the hiring of qualified and trustworthy employees through its automated screening processes.
SnapDragon Monitoring
Venture Round in 2021
SnapDragon Monitoring Limited is a company based in Edinburgh, United Kingdom, that specializes in brand protection software solutions. Established in 2014, it offers both managed and self-service options to help businesses safeguard their brand reputations. One of its key products is Swoop, a software designed specifically for brand protection. By focusing on small and medium-sized enterprises, SnapDragon Monitoring aims to create a safer marketplace for consumers while supporting the growth of businesses.
Kuano
Seed Round in 2021
Kuano Ltd specializes in developing quantum and AI solutions aimed at molecular design, particularly in the fields of drug discovery and development. Founded in 2020 and based in London, the company integrates quantum simulation with machine learning to create effective enzyme inhibitors. Its innovative discovery platform employs target quantum mapping alongside AI-driven chemistry, facilitating the faster and more efficient development of superior drug candidates. Kuano's technology is applicable across several sectors, including pharmaceuticals, crop protection, and industrial chemistry, ultimately enhancing the quality of new therapeutics while reducing the time required for their discovery.
Scene Group
Seed Round in 2021
Cavalry is a brand new professional level motion design and animation application conceived and created by artists.
VenueScanner
Venture Round in 2021
VenueScanner operates as a two-sided marketplace focused on facilitating venue search and booking for event organizers. The platform caters to a wide range of events, from meetings to yoga sessions and parties, addressing the challenges of discovering and booking venues online. With over 14,000 venues listed, organizers can easily find, favorite, inquire, and book spaces directly, without intermediaries, through a user-friendly interface. VenueScanner also serves as a digital marketing tool for venue hosts, enabling them to promote their under-utilized spaces. The platform allows venues to list themselves in just five minutes, contributing to a more efficient and cost-effective booking process. With a data-led approach, VenueScanner operates in major cities across the UK, including London, Edinburgh, and Manchester, making it a valuable resource in the events industry. Founded by experienced professionals in e-commerce and digital marketing, the company aims to enhance the consumer experience in venue booking.
Micrima
Series A in 2021
Micrima Limited is a company based in Bristol, United Kingdom, specializing in the development and commercialization of advanced imaging technology for early breast cancer detection. The firm has created an ergonomic imaging system branded as MARIA, which employs microwave radar technology to provide non-ionizing imaging services. This system features a horizontal couch and a hemispherical scanning head designed to accommodate various breast sizes without the need for breast compression, offering a more comfortable experience for patients. Micrima is also focused on developing algorithms for processing the data collected during imaging. Initially spun out from research at the University of Bristol, the company has conducted extensive laboratory validation of its technology and is currently conducting human use trials. Micrima primarily serves breast cancer imaging centers and healthcare providers across the UK, aiming to provide a painless and efficient alternative for routine breast cancer screening.
AdaptTech
Venture Round in 2021
AdaptTech is a biomedical company based in Birmingham, United Kingdom, that specializes in developing innovative wearable technologies aimed at enhancing the quality of life for individuals with physical disabilities. Founded in 2015, the company offers a range of products designed to assist clinicians in achieving better socket fitting and monitoring for patients who have lost a lower limb. Key offerings include the INSIGHT Scanner, which quickly creates a three-dimensional model of prosthetic sockets, the INSIGHT Wearable that collects real-time biometric data, and the INSIGHT App that provides users with easy access to their results. Through these advancements, AdaptTech seeks to improve the overall experience and outcomes for those relying on lower limb prosthetics.
Antiverse
Seed Round in 2021
Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.
Axis Spine Technologies
Seed Round in 2021
Axis Spine Technologies is building an expert team to develop highly differentiated products that provide meaningful improvements in patient care.
Nozzle.ai
Seed Round in 2020
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
HR DataHub
Seed Round in 2020
HR DataHub is a provider of a human resource intelligence platform designed to support companies in making informed decisions related to compensation and employee rewards. The platform offers comprehensive benchmark data across various HR domains, including diversity, women in leadership, employee relations, recruitment, engagement, talent development, and the gender pay gap. By delivering robust and credible data, HR DataHub enables organizations to foster fairness and competitiveness in their workplace practices, helping them to become more equitable and appealing employers.
Spotta
Seed Round in 2020
Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.
Neurovalens
Venture Round in 2020
Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.
BrainWaveBank
Seed Round in 2020
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
Scoota
Venture Round in 2020
Scoota is an online advertising technology company that enables advertisers to create, activate, measure and optimise brilliant brand campaigns at scale. We offer a single programmatic platform for the creation and delivery of rich, high-impact formats via open real-time bidding and private marketplaces, without compromising creative execution or brand safety. Our technology includes a unique campaign delivery system that pre-reads an ad space in real-time so that the right creative is delivered into the right ad unit without the need for pre-testing and independent site integration. We care about and invest in an open and long-term approach, enabling partners to work with us through integration with their own systems of choice, or via our platform whether as a self-serve solution, or a fully managed service. Scoota was founded in London in 2008 and employs more than 40 people. In 2015, we won best overall programmatic technology at The Drum Digital Trading Awards and Silver for Best Ad Tech Provider at the 2015 British Media Awards.
DPL
Seed Round in 2020
DPL provides an automated marketing product based on behavioural science.
Wayland Additive
Series A in 2019
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
BrainWaveBank
Seed Round in 2019
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
Qube
Seed Round in 2019
Qube is a provider of private studio and co-working spaces tailored for content creators. It offers access to 30 purpose-built studios designed for music, podcasting, photography, and video editing. The flagship location in West London spans 16,000 square feet and was inaugurated in February 2020. By creating a collaborative environment, Qube enables its members to share resources and connect with other creatives, facilitating the professional writing, production, and recording processes. The space is specifically crafted to support the needs of inspired creators, fostering an atmosphere where they can thrive.
Adventoris
Venture Round in 2019
Adventoris specialises in the development of ground breaking Mobile Business Software. Given the huge changes in technology, and its revolutionary impact on the way we live and work, Adventoris is seeking to capitalise on this tremendous opportunity.
Autologyx
Seed Round in 2019
Autologyx Ltd. is a company based in Farnborough, United Kingdom, that specializes in developing cloud-based applications aimed at automating complex business processes. Founded in 2011 and originally known as NowWeComply Limited before rebranding in 2017, Autologyx offers a no-code digital operations platform designed for various industries, with a particular emphasis on the legal and professional services sectors. The platform enables users to create, modify, and deploy tailored workspaces, facilitating the automation of tasks ranging from simple to intricate processes. It integrates seamlessly with third-party systems, allowing for efficient management of claims, asset management, compliance, and governance. By providing a comprehensive solution that displaces traditional point solutions, Autologyx addresses the unique challenges of legal and compliance workflows.
Nivo
Series A in 2019
Nivo is a developer of an instant messaging platform tailored for the financial services sector, combining bank-standard identity verification with secure communication. The platform allows users to engage with clients while ensuring that both parties can trust each other's identities. It facilitates identification verification checks and enables the secure exchange of files, images, and information. Additionally, Nivo incorporates features such as open banking and electronic signatures, streamlining the process for banks and companies to identify customers and share essential documents efficiently.
Neurovalens
Series A in 2019
Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.
Gousto
Series E in 2019
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by two friends, the company was born out of a desire to simplify home cooking by providing all the necessary ingredients in the right proportions, eliminating the need for multiple grocery trips. Each week, subscribers can choose from a selection of new recipes developed by a team of professional chefs, ensuring a diverse range of cuisines and styles. Customers have the flexibility to pause their subscription as needed, making it convenient for those with busy lifestyles. Gousto's approach combines quality with ease, enabling individuals and families to prepare delicious and healthy meals at home without the hassle of planning or shopping.
Techspert
Seed Round in 2018
Techspert is an expert network platform that leverages artificial intelligence to facilitate primary research and business intelligence across various sectors. Originally focused on healthcare, the company was founded by Graham and David, who recognized the challenges of connecting with the right experts. With the addition of co-founder Hari, they developed an AI-driven solution capable of analyzing and indexing extensive online content to create accurate expert profiles. This technology enables businesses to connect with key opinion leaders and obtain domain-specific insights efficiently. Techspert's team includes professionals with backgrounds in computer science, software development, and client relations, and the company currently serves large consultancies and private equity groups. Committed to democratizing access to knowledge, Techspert aims to revolutionize the way expertise is exchanged while adhering to core values of curiosity, empathy, commitment, and ambition.
Micrima
Venture Round in 2018
Micrima Limited is a company based in Bristol, United Kingdom, specializing in the development and commercialization of advanced imaging technology for early breast cancer detection. The firm has created an ergonomic imaging system branded as MARIA, which employs microwave radar technology to provide non-ionizing imaging services. This system features a horizontal couch and a hemispherical scanning head designed to accommodate various breast sizes without the need for breast compression, offering a more comfortable experience for patients. Micrima is also focused on developing algorithms for processing the data collected during imaging. Initially spun out from research at the University of Bristol, the company has conducted extensive laboratory validation of its technology and is currently conducting human use trials. Micrima primarily serves breast cancer imaging centers and healthcare providers across the UK, aiming to provide a painless and efficient alternative for routine breast cancer screening.
SonicJobs
Seed Round in 2018
SonicJobs is an online recruitment platform focused on the hospitality and retail industries, offering innovative solutions to enhance the talent acquisition process. The platform utilizes proprietary AI Web Agents that allow candidates to apply directly on any site without being redirected to the employer's career site, significantly reducing candidate drop-off rates. This seamless application process leads to a conversion rate of 26%, compared to the industry average of just 5%. By employing advanced chatbot technology, SonicJobs effectively screens applicants based on their experience, skills, and desired characteristics, ensuring a better match for job vacancies. The platform also facilitates B2B connectivity, allowing employers and their applicant tracking systems to integrate without the need for complex API developments, and operates on a pay-per-application model, making it a cost-effective solution for businesses.
Gousto
Series D in 2018
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by two friends, the company was born out of a desire to simplify home cooking by providing all the necessary ingredients in the right proportions, eliminating the need for multiple grocery trips. Each week, subscribers can choose from a selection of new recipes developed by a team of professional chefs, ensuring a diverse range of cuisines and styles. Customers have the flexibility to pause their subscription as needed, making it convenient for those with busy lifestyles. Gousto's approach combines quality with ease, enabling individuals and families to prepare delicious and healthy meals at home without the hassle of planning or shopping.
BMLL
Seed Round in 2017
BMLL Technologies Ltd. is a financial data company based in London, established in 2014. It operates a cloud-based platform that provides advanced analytics and historical data specifically for capital market participants. The platform utilizes machine learning and inference frameworks to analyze limit order book data from various global financial markets, enabling clients to gain insights into market behavior and forecast price movements. BMLL offers immediate access to standardized Level 3 data, which includes the trading intentions of all market participants, along with pre and post-trade analytics. This service is particularly beneficial for investment banks, hedge funds, asset managers, and academic institutions, allowing them to conduct tasks such as order book simulation, back-testing, risk assessment, and compliance measurement without the need to purchase or curate their own data. BMLL's Data Science as a Service platform is designed for flexibility and scalability, providing users with extensive computational resources and a comprehensive historical record of detailed order book data across various asset classes.
BMLL
Venture Round in 2017
BMLL Technologies Ltd. is a financial data company based in London, established in 2014. It operates a cloud-based platform that provides advanced analytics and historical data specifically for capital market participants. The platform utilizes machine learning and inference frameworks to analyze limit order book data from various global financial markets, enabling clients to gain insights into market behavior and forecast price movements. BMLL offers immediate access to standardized Level 3 data, which includes the trading intentions of all market participants, along with pre and post-trade analytics. This service is particularly beneficial for investment banks, hedge funds, asset managers, and academic institutions, allowing them to conduct tasks such as order book simulation, back-testing, risk assessment, and compliance measurement without the need to purchase or curate their own data. BMLL's Data Science as a Service platform is designed for flexibility and scalability, providing users with extensive computational resources and a comprehensive historical record of detailed order book data across various asset classes.
VenueScanner
Seed Round in 2017
VenueScanner operates as a two-sided marketplace focused on facilitating venue search and booking for event organizers. The platform caters to a wide range of events, from meetings to yoga sessions and parties, addressing the challenges of discovering and booking venues online. With over 14,000 venues listed, organizers can easily find, favorite, inquire, and book spaces directly, without intermediaries, through a user-friendly interface. VenueScanner also serves as a digital marketing tool for venue hosts, enabling them to promote their under-utilized spaces. The platform allows venues to list themselves in just five minutes, contributing to a more efficient and cost-effective booking process. With a data-led approach, VenueScanner operates in major cities across the UK, including London, Edinburgh, and Manchester, making it a valuable resource in the events industry. Founded by experienced professionals in e-commerce and digital marketing, the company aims to enhance the consumer experience in venue booking.
Limejump
Series A in 2017
Limejump Limited is an energy technology company based in London, United Kingdom, specializing in the development and operation of a Virtual Power Plant (VPP) platform. Founded in 2012, Limejump provides optimized access to the energy market for customers with electricity-generating or consuming assets. Its platform integrates various components, including cloud-based software, smart devices, and analytical tools, to connect and optimize asset performance. Limejump offers products such as the Balancing Mechanism, which aids the National Grid in managing electricity supply and demand, as well as Power Purchase Agreements (PPAs) to enhance the value of electricity generation. Additionally, the company facilitates participation in demand response programs, allowing generators to adjust energy output and businesses to modify their energy consumption, thereby supporting grid stability. As of early 2019, Limejump operates as a subsidiary of The Shell Petroleum Company Limited.
Neurovalens
Seed Round in 2017
Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.
Form3
Series A in 2017
Form3 is a London-based company that provides cloud-based payment processing, clearing, and settlement services tailored for regulated financial institutions. Established in 2016, it offers a fully managed payment technology service built on a robust AWS cloud processing platform. Form3's architecture includes multiple payment gateways and a micro-services framework, allowing clients to access a comprehensive range of payment schemes through a single application programming interface (API). This technology facilitates secure and reliable agency payment services on a per-transaction basis without upfront costs. Its clientele consists of various financial entities, including leading banks, non-bank financial institutions, and fintech companies, such as payment institutions and e-money providers.
Small Pharma
Seed Round in 2017
Small Pharma applies expert intellectual property design to guide academic discovery to commercial product. We operate a scalable model of outsourced drug development. We assemble specific expert teams to design and execute development programs with demonstrated track-records in all disciplines essential to their success.
Vantage Power
Venture Round in 2017
Vantage Power Ltd. specializes in designing and manufacturing electric and hybrid systems for buses and heavy-duty vehicles. Founded in 2011 and based in London, the company provides a range of hybrid and electric powertrain solutions, including hybrid battery systems, drive systems, range extenders, and custom battery solutions. Vantage Power focuses on retrofitting existing buses with hybrid powertrains, allowing operators to significantly reduce fuel consumption and emissions without the high costs associated with acquiring new hybrid vehicles. The company's engineering team, which includes experts from the heavy-duty vehicle, Formula 1, and aerospace sectors, is dedicated to creating innovative solutions that ensure optimal performance, fuel efficiency, and reliability. Additionally, Vantage Power offers technologies related to system design, telemetry, control systems, and battery management. As of 2019, Vantage Power operates as a subsidiary of Allison Transmission Holdings, Inc.
Medallia Video
Series B in 2017
LivingLens unlocks the power of video for brands, agencies and technology providers, transforming video content into a usable data asset enabling fast customer insight generation and powerful storytelling. Operating in 44 languages, LivingLens provides solutions for capturing, mining, analysing and sharing consumer video content to accelerate the value of consumer insight and customer experience feedback.
Exonate
Angel Round in 2016
Exonate is a privately held, early stage, biotech company spun out of the University of Nottingham that is focused on alternative splicing of Vascular Endothelial Growth Factor (VEGF) in ophthalmology. Exonate’s lead programme is focused on Diabetic Macular Oedema (DMO). A consequence of diabetic retinopathy, DMO, is swelling in an area of the retina called the macula and wet Age-Related Macular Degeneration (wAMD), which is the leading cause of vision loss in people aged 60 and older. The Company is founded on scientific excellence with strong links to Professor David Bates and his lab at Nottingham University specializing in the biology and biochemical pathways of VEGF splice variants. Exonate have developed small molecules that inhibit production of pro-angiogenic VEGF through selective inhibition of serine/threonine-protein kinase 1 (SRPK1)-mediated VEGF splicing. These inhibitors have already demonstrated superior efficacy as topical agents in preclinical models of wet AMD. Through a Wellcome Trust funded project, Exonate has completed an optimization programme and has nominated a pre-clinical candidate drug with optimal characteristics. During the second quarter of 2020 regulatory toxicology and safety pharmacology studies have taken place. This is to support the successful application to the regulatory authorities for clinical evaluation. Exonate is led by an experienced, international management team that has previously worked together with cross-disciplinary experience in medicine and drug development, as well as successful fundraising for early stage companies. About Diabetic Macular Oedema (DMO)*: DMO is the build-up of fluid (Oedema) in a region of the retina called the macula. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. DMO is the most common cause of vision loss among people with diabetic retinopathy. About half of all people with diabetic retinopathy will develop DMO and although it is more likely to occur as diabetic retinopathy worsens, DMO can happen at any stage of the disease. About wet Age-Related Macular Degeneration (wet AMD): Today, wet AMD is a leading cause of vision loss in people aged 60 years or older and affects more than 30 million patients worldwide, over 200,000 of those in the UK alone. If untreated patients are likely to lose sight in the affected eye within 24 months of disease onset. The main currently available treatment options for DMO and wet AMD are: • anti-VEGF antibody drugs – to prevent the growth of new blood vessels in the eye. Unlike small molecule drugs or eye drops these treatments must be injected into the eye once every 1 or 2 months. Resistance can develop to these drugs causing the disease to progress anew. • Laser surgery – to destroy abnormal blood vessels in the eye. This type of surgery is only suitable if blood vessel damage is not too extensive and if the abnormal blood vessels aren't close to the fovea, as performing surgery close to this part of the eye can cause permanent vision loss. • With DMO, Corticosteroids either injected or implanted into the eye, may be used alone or in combination with other drugs or laser surgery to treat DMO. *source: https://nei.nih.gov/health/diabetic/retinopathy
4040 Media
Venture Round in 2016
4040 Media is a group of brands, through which we help our clients attract, educate, nurture and support their customers. We’re passionate about creating exceptional content that speaks to it’s intended audience and helps move people through their buying journey. You can find out more about each of our brands below…
Gousto
Series C in 2016
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by two friends, the company was born out of a desire to simplify home cooking by providing all the necessary ingredients in the right proportions, eliminating the need for multiple grocery trips. Each week, subscribers can choose from a selection of new recipes developed by a team of professional chefs, ensuring a diverse range of cuisines and styles. Customers have the flexibility to pause their subscription as needed, making it convenient for those with busy lifestyles. Gousto's approach combines quality with ease, enabling individuals and families to prepare delicious and healthy meals at home without the hassle of planning or shopping.
BrainWaveBank
Seed Round in 2016
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
Keit
Venture Round in 2016
Keit Ltd. specializes in the design and manufacture of advanced spectrometers and related instruments that operate across a spectrum from ultraviolet to far infrared rays. Established in 2012 and based in Didcot, United Kingdom, the company focuses on innovative applications for its products, which include the measurement of signal levels, vibrations, and various substances in both gas and liquid forms. One of Keit's flagship products is the microFTS®, a compact and rugged Fourier Transform Infrared (FTIR) spectrometer originally developed for space applications. This device sets a new benchmark for real-time liquid-state analyses and serves industries such as pharmaceuticals, chemicals, oil and gas, and food and beverage, where performance in extreme environments is crucial.
City Pantry
Seed Round in 2016
City Pantry is an online marketplace where users can discover interesting food for next event. City Pantry is on a mission to rid the world of egg mayonnaise triangles, stale sandwiches and vol-au-vents by disrupting the (slightly boring) world of traditional corporate catering. Working with the best independent chefs, street vendors, specialist caterers, restaurants, and supper clubs in London, City Pantry makes it easy to cater office lunches, meetings, and events.
Saberr
Venture Round in 2016
Saberr Limited, established in 2013 and based in London, United Kingdom, specializes in predicting startup success through advanced mathematics and psychology algorithms. The company offers innovative software designed to enhance workplace dynamics by providing tools for managers to build trust, improve team performance, and streamline collaboration. Its platform features online surveys that analyze working relationships, as well as resources for one-on-one meetings and team interactions. By focusing on developing leadership capabilities and adapting to agile and remote work environments, Saberr aims to support organizations in optimizing their performance and fostering effective teamwork.
Gousto
Series B in 2015
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by two friends, the company was born out of a desire to simplify home cooking by providing all the necessary ingredients in the right proportions, eliminating the need for multiple grocery trips. Each week, subscribers can choose from a selection of new recipes developed by a team of professional chefs, ensuring a diverse range of cuisines and styles. Customers have the flexibility to pause their subscription as needed, making it convenient for those with busy lifestyles. Gousto's approach combines quality with ease, enabling individuals and families to prepare delicious and healthy meals at home without the hassle of planning or shopping.
Monterosa Productions
Series A in 2015
Monterosa Productions Ltd specializes in audience interaction technology, offering a cloud platform that enhances engagement for content creators and developers across various media. The company provides a suite of products that facilitate live games, voting, competitions, and sports experiences, specifically designed for television shows and events. Its key offerings include LViS for television, a scalable interaction platform with embeddable applications; LViS for brands, which integrates interactive content across multiple screens; and LViS for sports, enabling audience participation through tracking, voting, and gaming. Monterosa collaborates with prominent clients in the entertainment and sports sectors, such as the BBC, ITV, and the English Premier League, to create immersive experiences that boost audience interactivity and loyalty. With a foundation established in 2003 and offices in London, Liverpool, and Minsk, the company boasts a team of experts dedicated to delivering reliable and innovative interactive solutions.
Exonate
Angel Round in 2015
Exonate is a privately held, early stage, biotech company spun out of the University of Nottingham that is focused on alternative splicing of Vascular Endothelial Growth Factor (VEGF) in ophthalmology. Exonate’s lead programme is focused on Diabetic Macular Oedema (DMO). A consequence of diabetic retinopathy, DMO, is swelling in an area of the retina called the macula and wet Age-Related Macular Degeneration (wAMD), which is the leading cause of vision loss in people aged 60 and older. The Company is founded on scientific excellence with strong links to Professor David Bates and his lab at Nottingham University specializing in the biology and biochemical pathways of VEGF splice variants. Exonate have developed small molecules that inhibit production of pro-angiogenic VEGF through selective inhibition of serine/threonine-protein kinase 1 (SRPK1)-mediated VEGF splicing. These inhibitors have already demonstrated superior efficacy as topical agents in preclinical models of wet AMD. Through a Wellcome Trust funded project, Exonate has completed an optimization programme and has nominated a pre-clinical candidate drug with optimal characteristics. During the second quarter of 2020 regulatory toxicology and safety pharmacology studies have taken place. This is to support the successful application to the regulatory authorities for clinical evaluation. Exonate is led by an experienced, international management team that has previously worked together with cross-disciplinary experience in medicine and drug development, as well as successful fundraising for early stage companies. About Diabetic Macular Oedema (DMO)*: DMO is the build-up of fluid (Oedema) in a region of the retina called the macula. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. DMO is the most common cause of vision loss among people with diabetic retinopathy. About half of all people with diabetic retinopathy will develop DMO and although it is more likely to occur as diabetic retinopathy worsens, DMO can happen at any stage of the disease. About wet Age-Related Macular Degeneration (wet AMD): Today, wet AMD is a leading cause of vision loss in people aged 60 years or older and affects more than 30 million patients worldwide, over 200,000 of those in the UK alone. If untreated patients are likely to lose sight in the affected eye within 24 months of disease onset. The main currently available treatment options for DMO and wet AMD are: • anti-VEGF antibody drugs – to prevent the growth of new blood vessels in the eye. Unlike small molecule drugs or eye drops these treatments must be injected into the eye once every 1 or 2 months. Resistance can develop to these drugs causing the disease to progress anew. • Laser surgery – to destroy abnormal blood vessels in the eye. This type of surgery is only suitable if blood vessel damage is not too extensive and if the abnormal blood vessels aren't close to the fovea, as performing surgery close to this part of the eye can cause permanent vision loss. • With DMO, Corticosteroids either injected or implanted into the eye, may be used alone or in combination with other drugs or laser surgery to treat DMO. *source: https://nei.nih.gov/health/diabetic/retinopathy
Creo Medical
Venture Round in 2015
Creo Medical Limited is a medical device manufacturer based in Chepstow, South Wales, specializing in the research and development of electrosurgical devices for surgical endoscopy. Established in 2003 and originally known as MicroOncology Ltd, the company focuses on innovative technologies that enhance surgical procedures. One of its key products is the Speedboat RS2, which integrates bipolar radiofrequency and microwave energy into a single platform for various applications, including tissue dissection, resection, ablation, and coagulation. Creo Medical operates from a modern facility equipped with controlled manufacturing areas, including a Class 6 Cleanroom, to support its research and development efforts.
Limejump
Seed Round in 2015
Limejump Limited is an energy technology company based in London, United Kingdom, specializing in the development and operation of a Virtual Power Plant (VPP) platform. Founded in 2012, Limejump provides optimized access to the energy market for customers with electricity-generating or consuming assets. Its platform integrates various components, including cloud-based software, smart devices, and analytical tools, to connect and optimize asset performance. Limejump offers products such as the Balancing Mechanism, which aids the National Grid in managing electricity supply and demand, as well as Power Purchase Agreements (PPAs) to enhance the value of electricity generation. Additionally, the company facilitates participation in demand response programs, allowing generators to adjust energy output and businesses to modify their energy consumption, thereby supporting grid stability. As of early 2019, Limejump operates as a subsidiary of The Shell Petroleum Company Limited.
Family Traveller
Seed Round in 2015
Family Traveller Limited operates an online portal designed to assist families in planning vacations with children of all ages. Founded in 2009 and based in London, the company provides comprehensive resources that include destination guides, travel tips, and recommendations for family-friendly accommodations and activities. Catering to parents traveling with babies, children, and teenagers, Family Traveller covers a wide array of travel options, from UK breaks to long-haul holidays. The platform aims to be a one-stop resource for practical advice and insights, ensuring families can make informed decisions for enjoyable trips. Additionally, the company publishes a magazine that offers further insights into various travel destinations worldwide.
upmysport
Seed Round in 2015
Home to the best instructors in Europe, we're on a mission to help people meet their perfect instructor and enjoy being active. We also help companies tackle employee inactivity by providing them with inspirational support and guidance from our premium instructors.
City Pantry
Seed Round in 2015
City Pantry is an online marketplace where users can discover interesting food for next event. City Pantry is on a mission to rid the world of egg mayonnaise triangles, stale sandwiches and vol-au-vents by disrupting the (slightly boring) world of traditional corporate catering. Working with the best independent chefs, street vendors, specialist caterers, restaurants, and supper clubs in London, City Pantry makes it easy to cater office lunches, meetings, and events.
LabMinds
Series A in 2015
LabMinds is the leader in AI and robotics for solution preparation in pharmaceutical and life science labs. A cornerstone of R&D and QA/QC processes, solution preparation continues to be a highly manual process with many moving parts, exposing labs to considerable risk and inevitable waste. LabMinds’ platform addresses these challenges with powerful AI software combined with state-of-the-art robotics to safeguard against tainted inputs, enable near-perfect accuracy, and attain unmatched control. Further, labs in the LabMinds network contribute to, and benefit from, the collection of input and sensor data throughout the solution prep process; it’s never been easier to gain detailed insight into how chemicals interact with each other. By implementing more security and order, and leveraging the power of big data, LabMinds moves ever closer to achieving its mission to enable scientists and businesses to build and optimize labs, in order to bring meaningful therapies to market sooner.
Ownfone
Angel Round in 2014
OwnFone is a mini, light, customisable mobile phone that just calls the people you need. It is ideal for people who don’t need or can’t use a smartphone. To make a call, simply press the name or picture of the person you want to call. You can have up to twelve names on your OwnFone and it receives calls too. It’s about the size of a credit card and comes with a matching lanyard so you can keep it on you at all times. The secret to the simplicity of their mobile phone is that it is made for each user. They deliver it to you ready to use, with no setup and within five working days. The OwnFone comes fully charged and with its own micro USB charger included. The charge will last about three days, although for simplicity they advise charging daily. OwnFone Handsets are designed to work with OwnFone Airtime
NorthRow
Angel Round in 2014
NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. It offers a suite of features that can be utilized individually or in conjunction, allowing users to conduct comprehensive checks on individuals, companies, and identification documents. The platform facilitates identity verification across various risk factors and integrates multiple data sources to authenticate businesses, as well as to verify essential documents like passports and visas. By digitizing compliance technologies, NorthRow streamlines onboarding processes and strengthens client due diligence through continuous monitoring of customer profiles, thereby enabling businesses to effectively manage regulatory risks and enhance customer experiences while ensuring compliance with relevant regulations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.